
About SA-FORD
SA-FORD is a Healthcare company based in Mumbai (India) founded in 2008. It provides chemistry, toxicology testing, and regulatory studies for clients. It operates on a B2B model in Healthcare and Chemicals & Materials sectors. The company has 257 employees. Its Indian entity Sharon Bio-Medicine Limited reported revenue of βΉ204 Cr. SA-FORD offers products and services including Analytical Testing, Impurity Profiling, and Reproductive and Developmental Testing. Its focus areas include Biotech, Toxicology, Regulatory Studies and Chemicals.
Company details
Sa-Ford specializes in chemistry, mutagenicity, and toxicological studies conducted in vivo and in vitro. They provide services like analytical testing, physico-chemical testing, and impurity profiling while adhering to guidelines such as OECD and ECHA. Operating from facilities in India and Europe, they serve clients in non-clinical regulatory research, ensuring quality and compliance. Their focus includes building global relationships through reliable services.
- Headquarters Mumbai, India
- Employees 257
- SectorsHealthcareChemicals & Materials
- Emailβ’β’β’β’β’β’β’β’
- Website sa-ford.com
- Social LinkedIn Facebook
- Legal Name Sharon Bio-Medicine Limited
- Date of Incorporation 19 Jun, 1989
- Jurisdiction Panvel, Maharashtra, India
- Annual Revenue₹204 Cr
FY 2025 · -20% YoY
- Net Profit₹23.18 Cr
FY 2025 · 11% margin
- EBITDA₹51.37 Cr
FY 2025 · 25% margin
- Employee Count257
Associated legal entities of SA-FORD
SA-FORD operates through Sharon Bio-Medicine Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Sharon Bio-Medicine Limited CIN U24110MH1989PLC052251 | Active | 19 Jun 1989 | Panvel, Maharashtra | ₹204 Cr | 258 | 7 | View details |
Products & Services of SA-FORD
SA-FORD offers a comprehensive portfolio of products and services, including Analytical Testing, Impurity Profiling, and Reproductive and Developmental Testing.
Conducts physico-chemical and impurity tests for regulatory compliance.
Analyzes impurities in substances for safety and quality assurance.
Performs studies on reproductive effects in compliance with guidelines.
Board of directors of Sharon Bio-Medicine Limited (SA-FORD)
Sharon Bio-Medicine Limited is the primary company behind SA-FORD. The board of Sharon Bio-Medicine Limited currently have 4 directors; the longest-serving is Purushottam Sharma, appointed in 2023. 21 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Purushottam Sharma DIN 08699409 | Director | 17 Jun 2023 | 3 yrs 5 mo | Sharon Bio-Medicine Limited |
| Mukeshkumar Siyaram Singh DIN 10186380 | Whole-time director | 17 Jun 2023 | 3 yrs 5 mo | Sharon Bio-Medicine Limited |
| Jayant Vasudeo Rao DIN 03627850 | Director | 17 Jun 2023 | 3 yrs 5 mo | Sharon Bio-Medicine Limited |
| Mahendar Korthiwada DIN 09558992 | Director | 29 Nov 2023 | 2 yrs 11 mo | Sharon Bio-Medicine Limited |
Financials of SA-FORD
Figures of Sharon Bio-Medicine Limited, the primary company behind SA-FORD, for FY 2025. Revenue was ₹204 Cr (-20% year on year). Net profit was ₹23.18 Cr (11% margin). EBITDA was ₹51.37 Cr (25% margin). Revenue has grown at a compounded annual rate of +2% over three years.
- ₹204 CrRevenue · FY 2025 · -20% YoY
- ₹23.18 CrNet profit · 11% margin
- ₹51.37 CrEBITDA · 25% margin
- ₹47,952Paid-up capital
- 258Employees (provident fund records)
- +2%Revenue CAGR, 3 years
Balance sheet, profit and loss, cash flow and ratios of Sharon Bio-Medicine Limited are on its company page.
Detailed financial statements for SA-FORD
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Sa-Ford
Complete news archive for SA-FORD
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about SA-FORD
SA-FORD was founded in 2008.
SA-FORD is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.
SA-FORD has 257 employees.
The primary company behind SA-FORD, Sharon Bio-Medicine Limited, reported revenue of βΉ204 Cr for FY 2025, down 20% year on year.
Sa-Ford specializes in chemistry, mutagenicity, and toxicological studies conducted in vivo and in vitro. They provide services like analytical testing, physico-chemical testing, and impurity profiling while adhering to guidelines such as OECD and ECHA. Operating from facilities in India and Europe, they serve clients in non-clinical regulatory research, ensuring quality and compliance. Their focus includes building global relationships through reliable services.
SA-FORD offers Analytical Testing, Impurity Profiling, and Reproductive and Developmental Testing.
SA-FORD operates through Sharon Bio-Medicine Limited.
The legal entities of SA-FORD currently have 7 directors, including Purushottam Sharma, Mukeshkumar Siyaram Singh, Mahendar Korthiwada and others.
